prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide non incretin anti - Peptidepredictor Prohormone cleavage prediction Prohormone Cleavage Prediction Uncovers a Non-Incretin Anti-Obesity Peptide

BRINP2peptide A groundbreaking study published in Nature has identified a novel peptide with significant anti-obesity effects, offering a potential new avenue for weight management. This discovery, stemming from advanced prohormone cleavage prediction, has uncovered a non-incretin anti-obesity peptide that acts independently of the well-known incretin hormones. The research team, including Laetitia Coassolo, utilized computational drug discovery tools to systematically map over 2,600 previously uncharacterized human proteolytic peptide fragments.In silico prohormone processing This innovative approach led to the identification of BRINP2-related peptide (BRP), a 12-mer peptide that demonstrates potent anti-obesity properties.

The significance of this finding lies in BRP's mechanism of action. Unlike existing weight-loss medications that often target incretin pathways, BRP functions through a different, non-incretin mechanism. This distinction is crucial as it suggests BRP may offer a distinct therapeutic profile and potentially bypass some of the side effects associated with incretin-based therapies. Early studies in animal models, including mice and pigs, have shown that pharmacological administration of BRP effectively reduces food intake and exhibits anti-obesity effects2025年3月19日—The researchers used AI-powered analysis and automated systems to uncover BRINP2-relatedpeptide(BRP), a 12-merpeptidethat effectively .... Encouragingly, these effects were observed without inducing nausea or aversion, which are common drawbacks of some current weight-loss treatments.作者：L Coassolo·2025·被引用次数：18—Here we use computational drug discovery to systematically map more than 2,600 previously uncharacterized human proteolyticpeptidefragments cleaved by ...

The computational tool developed for this research, named PeptidePredictor, plays a central role in this discovery作者：L Coassolo·2025—We developedPeptidePredictor, a computational drug discovery tool that systematically maps over 2,600 previously uncharacterized human .... This sophisticated system is designed to predict peptides based on the presence of protein cleavage sites, enabling researchers to identify and characterize novel peptide fragments that were previously unknown.Discovery of peptides as key regulators of metabolic and ... The ability to systematically map these fragments is a significant advancement in peptide discovery and opens doors for further exploration of the human proteome for therapeutic targets.

The identified BRINP2-related peptide (BRP) is derived from the BRINP2 protein. Its discovery highlights the potential of exploring prohormone processing pathways to uncover new bioactive molecules作者：L Coassolo·2025·被引用次数：18—We identified a 12-merpeptide, BRINP2-relatedpeptide(BRP). When administered pharmacologically, BRP reduces food intake and exhibitsanti-obesity effects.. The obesity peptide research landscape is constantly evolving, and the identification of a non-incretin agent like BRP represents a notable step forward.2025年5月20日—Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide. Nature. 2025 May;641(8061):192-201. doi: 10.1038/s41586-025 ... The research also touches upon the broader field of prohormone cleavage prediction, a critical process in understanding how larger precursor proteins are processed into smaller, functional peptides within the body作者：Z Zhang·2025—Patel, et al.Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide. Nature, 641 (2025), pp. 192-201, 10.1038/s41586 ....

While the initial findings are promising, further research is necessary to fully understand BRP's efficacy and safety in humans. However, the discovery of this obesity peptide through advanced computational methods, such as those employed in prohormone cleavage prediction, marks a significant milestone. The potential for a peptide that can curb appetite and promote weight loss through a novel mechanism, independent of the incretin system, offers a beacon of hope for individuals struggling with obesity. The study, and its implications for peptide therapeutics, are generating considerable interest within the scientific community, with discussions on platforms like Reddit exploring the potential of BRP peptide and its natural sources. The exploration of BRINP2 peptide and related research underscores the power of artificial intelligence and computational drug discovery in revolutionizing our understanding and treatment of complex health conditions.